These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2106783)

  • 1. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
    Goldhaber SZ; Meyerovitz MF; Green D; Vogelzang RL; Citrin P; Heit J; Sobel M; Wheeler HB; Plante D; Kim H
    Am J Med; 1990 Mar; 88(3):235-40. PubMed ID: 2106783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
    Turpie AG; Levine MN; Hirsh J; Ginsberg JS; Cruickshank M; Jay R; Gent M
    Chest; 1990 Apr; 97(4 Suppl):172S-175S. PubMed ID: 2108855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis.
    Verhaeghe R; Besse P; Bounameaux H; Marbet GA
    Thromb Res; 1989 Jul; 55(1):5-11. PubMed ID: 2506661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator for the treatment of deep venous thrombosis of the lower extremity: a systematic review.
    Forster A; Wells P
    Chest; 2001 Feb; 119(2):572-9. PubMed ID: 11171740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
    Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
    Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment trials of plasminogen activator (rt-PA) in central vein thrombosis of the retina].
    Reim M; Bertram B; Wolf S
    Klin Wochenschr; 1988; 66 Suppl 12():143-9. PubMed ID: 3126343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study.
    Schweizer J; Elix H; Altmann E; Hellner G; Forkmann L
    Vasa; 1998 Aug; 27(3):167-71. PubMed ID: 9747153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term results after thrombolytic treatment of deep venous thrombosis.
    Schweizer J; Kirch W; Koch R; Elix H; Hellner G; Forkmann L; Graf A
    J Am Coll Cardiol; 2000 Oct; 36(4):1336-43. PubMed ID: 11028492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
    Schranz D; Haugwitz D; Zimmer B; Schumacher R
    Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators.
    Chest; 1990 Mar; 97(3):528-33. PubMed ID: 2106408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding complications associated with the use of rt-PA versus r-PA for peripheral arterial and venous thromboembolic occlusions.
    McNamara TO; Dong P; Chen J; Quinn B; Gomes A; Goodwin S; Aban K
    Tech Vasc Interv Radiol; 2001 Jun; 4(2):92-8. PubMed ID: 11981794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation alterations due to local fibrinolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease.
    Rauber K; Heidinger KS; Kemkes-Matthes B
    Cardiovasc Intervent Radiol; 1997; 20(3):169-73. PubMed ID: 9134838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT)--a German multicenter trial.
    Schwieder G; Grimm W; Siemens HJ; Flor B; Hilden A; Gmelin E; Friedrich HJ; Wagner T
    Thromb Haemost; 1995 Nov; 74(5):1240-3. PubMed ID: 8607102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
    Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
    Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of therapeutic doses of heparin on thrombolysis with tissue-type plasminogen activator in rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Blood; 1990 Nov; 76(10):2030-6. PubMed ID: 2122919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of heparin for arterial and venous thrombolysis with recombinant tissue-type plasminogen activator.
    Rapold HJ; Lu HR; Wu ZM; Nijs H; Collen D
    Blood; 1991 Mar; 77(5):1020-4. PubMed ID: 1899806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.